Decibel Therapeutics Inc. (DBTX) NASDAQ
$4.91 (0.04) (-0.81%)
Market Cap: -
As of 09/22/23 04:00 PM EDT. Market closed.
Decibel Therapeutics Inc. (DBTX)
NASDAQ
$4.91
(0.04) (-0.81%)
Market Cap: -
As of 09/22/23 04:00 PM EDT. Market closed.
decibel therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair and restore hearing. hearing loss is the most prevalent form of sensory impairment. it is estimated that 50 million people in the u.s., and 360 million people worldwide, suffer from some type of hearing loss. hearing disorders affect people of all ages and can have a profound impact on ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Trask Anna | See Remarks | Dec 02, 2021 | Sale | $6.37 | 5,291 | 33,688 | 2,620 | Dec 06, 2021, 04:20 PM |
Trask Anna | See Remarks | Nov 03, 2021 | Sale | $8.34 | 378 | 3,152 | 7,533 | Nov 04, 2021, 08:00 AM |
Trask Anna | SEE REMARKS | Nov 02, 2021 | Sale | $8.31 | 4,913 | 40,827 | 7,911 | Nov 03, 2021, 04:16 PM |
Trask Anna | See Remarks | Oct 14, 2021 | Sale | $7.55 | 5,364 | 40,481 | 12,824 | Oct 15, 2021, 04:57 PM |
Reid Laurence | President and Chief Executive | Sep 15, 2021 | Buy | $7.64 | 10,000 | 76,400 | 25,849 | Sep 17, 2021, 09:48 PM |
ORBIMED ADVISORS LLC | Director | Feb 17, 2021 | Buy | $18.00 | 1,666,666 | 29,999,988 | 3,843,206 | Feb 19, 2021, 07:09 PM |
Foy Matthew | Director | Feb 17, 2021 | Buy | $18.00 | 150,000 | 2,700,000 | 1,183,663 | Feb 19, 2021, 06:59 PM |
Casdin Partners Master Fund, L.P. | 10% Owner | Feb 17, 2021 | Buy | $18.00 | 575,000 | 10,350,000 | 1,121,421 | Feb 19, 2021, 06:56 PM |
Thompson Peter A. | Director | Feb 17, 2021 | Buy | $18.00 | 1,666,666 | 29,999,988 | 3,843,206 | Feb 19, 2021, 06:50 PM |
GLAXOSMITHKLINE PLC | Director | Feb 17, 2021 | Buy | $18.00 | 150,000 | 2,700,000 | 1,183,663 | Feb 19, 2021, 04:50 PM |
Owner | Relationship | Date | Value($) |
Trask Anna | See Remarks | 12/02/2021 | 33,688 |
Trask Anna | See Remarks | 11/03/2021 | 3,152 |
Trask Anna | SEE REMARKS | 11/02/2021 | 40,827 |
Trask Anna | See Remarks | 10/14/2021 | 40,481 |
Reid Laurence | President and Chief Executive | 09/15/2021 | 76,400 |
ORBIMED ADVISORS LLC | Director | 02/17/2021 | 29,999,988 |
Foy Matthew | Director | 02/17/2021 | 2,700,000 |
Casdin Partners Master Fund, L.P. | 10% Owner | 02/17/2021 | 10,350,000 |
Thompson Peter A. | Director | 02/17/2021 | 29,999,988 |
GLAXOSMITHKLINE PLC | Director | 02/17/2021 | 2,700,000 |
Period of Report: 06/30/2023
10-K/10-Q Filings: View